Bottom line
What is NSMRX's expense ratio?
NSMRX's expense ratio is 1.03%, or about $103 a year on every $10,000 invested. That is more expensive than 64% of mid-cap funds we track (median 0.88%). It has no front-end sales load.
Updated Oct 28, 2026
NSMRX fee table
| Net expense ratio | 1.03% |
|---|---|
| Gross expense ratio | 1.06% |
| Management fee | 0.76% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.3% |
| Fee waiver / reimbursement | -0.03% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Oct 28, 2026
What NSMRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| NSMRX | $105 | $332 | $580 | $1,289 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.03% expense ratio costs roughly $56,900 in lost growth, versus about $49,300 for the median mid-cap fund (0.88%).